| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ANTARES PHARMA INC | 45,000 | 94,000 | 0.08% | ||
| 2 | CHECK CAP LTD | 55,000 | 96,000 | 0.08% | ||
| 3 | CAS MED SYS INC | 88,522 | 113,000 | 0.10% | ||
| 4 | CORBUS PHARMACEUTICALS HLDGS | 36,590 | 113,000 | 0.10% | ||
| 5 | TRANSITION THERAPEUTICS INC | 59,222 | 124,000 | 0.10% | ||
| 6 | CHEMBIO DIAGNOSTICS INC COM NEW | 26,287 | 129,000 | 0.11% | SH | |
| 7 | ONCOTHYREON INC COM N/C EFF 6/ | 36,180 | 135,000 | 0.11% | SH | |
| 8 | Caladrius Biosciences Inc | 88,900 | 166,000 | 0.14% | ||
| 9 | Biotie Therapies Corp. | 10,000 | 200,000 | 0.17% | ||
| 10 | GENVEC INC | 100,000 | 204,000 | 0.17% | SH | |
| 11 | CEL SCI CORP | 316,500 | 209,000 | 0.18% | ||
| 12 | LOXO ONCOLOGY INC COM | 12,245 | 221,000 | 0.19% | ||
| 13 | Nivalis Therapeutics Inc | 15,000 | 227,000 | 0.19% | ||
| 14 | ACTINIUM PHARMACEUTICALS INC | 90,000 | 239,000 | 0.20% | ||
| 15 | Marinus Pharmaceuticals Inc | 22,319 | 259,000 | 0.22% | ||
| 16 | VENAXIS INC | 658,000 | 295,000 | 0.25% | SH | |
| 17 | Pieris Pharmaceuticals | 125,000 | 344,000 | 0.29% | ||
| 18 | APTOSE BIOSCIENCES INC | 70,396 | 359,000 | 0.30% | ||
| 19 | CHECK CAP LTD | 110,000 | 385,000 | 0.33% | ||
| 20 | AFFIMED N V COM | 28,950 | 390,000 | 0.33% | SH | |
| 21 | TANDEM DIABETES CARE INC COM | 35,992 | 390,000 | 0.33% | ||
| 22 | IRONWOOD PHARMA | 400,000 | 396,000 | 0.33% | PRN | |
| 23 | LUMENIS LTD | 31,072 | 426,000 | 0.36% | SH | |
| 24 | INTERCEPT PHARMACEUTICALS INCORPORATED | 2,000 | 483,000 | 0.41% | SH | |
| 25 | RTI SURGICAL HOLDINGS INC COM | 85,918 | 555,000 | 0.47% | SH | |
| 26 | CYNAPSUS THERAPEUTICS INC | 33,995 | 559,000 | 0.47% | SH | |
| 27 | COGENTIX MED INC | 353,181 | 572,000 | 0.48% | ||
| 28 | ENCISION INC | 1,062,500 | 584,000 | 0.49% | SH | |
| 29 | ARCA BIOPHARMA INC COM NEW | 567,859 | 653,000 | 0.55% | ||
| 30 | Exactech Inc | 31,636 | 659,000 | 0.56% | SH | |
| 31 | LIPOCINE INC NEW | 85,000 | 729,000 | 0.62% | ||
| 32 | CARDICA INC | 1,486,004 | 742,000 | 0.63% | SH | |
| 33 | Arena Pharmaceuticals, Inc | 189,000 | 877,000 | 0.74% | ||
| 34 | JOHNSON & JOHNSON | 9,400 | 916,000 | 0.77% | SH | |
| 35 | SPECTRANETICS CORP | 39,812 | 916,000 | 0.77% | SH | |
| 36 | CAREDX INC | 145,627 | 947,000 | 0.80% | SH | |
| 37 | SYNERON MEDICAL LTD | 90,947 | 966,000 | 0.82% | SH | |
| 38 | NUVASIVE INC | 760,000 | 968,000 | 0.82% | PRN | |
| 39 | DERMIRA INC COM | 56,736 | 996,000 | 0.84% | ||
| 40 | BLUEBIRD BIO INC COM | 6,000 | 1,010,000 | 0.85% | SH | |
| 41 | UNIQURE NV | 40,000 | 1,080,000 | 0.91% | SH | |
| 42 | CYTRX CORP | 300,813 | 1,119,000 | 0.95% | SH | |
| 43 | DICERNA PHARMACEUTICALS INC | 86,800 | 1,211,000 | 1.02% | ||
| 44 | NOVADAQ TECHNOLOGIES INC | 101,841 | 1,233,000 | 1.04% | SH | |
| 45 | TARGACEPT INC | 463,914 | 1,294,000 | 1.09% | SH | |
| 46 | SCYNEXIS INC | 161,382 | 1,419,000 | 1.20% | SH | |
| 47 | ZOGENIX INC | 853,700 | 1,434,000 | 1.21% | ||
| 48 | CARA THERAPEUTICS INC | 126,956 | 1,543,000 | 1.31% | ||
| 49 | CELYAD SA | 30,000 | 1,561,000 | 1.32% | ||
| 50 | Ascendis Pharma | 93,541 | 1,654,000 | 1.40% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-15-000016, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
